Skip to content
Open in App
Hoya Corp logo

HOYA Corporation

web2

HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asi...

Symbol · HOCPY
Company profile

About

HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses; contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics, brain surgery, and dentistry. The company also operates Eyecity, a specialty retailer of contact lenses. In addition, it provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging related products that comprise optical glasses/optical lenses, colored glass filters, and UV light resources. Further, the company engages in research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. HOYA Corporation was founded in 1941 and is headquartered in Shinjuku, Japan.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Singapore mask blank capacity expansion approved

KEY STEP

HOYA announced the construction of an additional facility at its Singapore site for semiconductor mask blank production. Total investment is expected to exceed ¥40 billion, with mass production planned for fiscal 2028.

Roadmap reference

New Vietnam HDD glass substrate facility approved

KEY STEP

HOYA announced an investment of approximately ¥50 billion to construct a new HDD glass substrate facility in Vietnam. The company expects the facility to begin contributing around fiscal 2028 and plans a staged ramp aligned with customer demand.

Roadmap reference

Strategic review of PENTAX Medical endoscope business launched

KEY STEP

HOYA's Board of Directors initiated a review of strategic options for the global PENTAX Medical endoscope business, including a possible transfer to a third party. No specific option, timing, transaction structure, method or terms had been decided at the announcement date.

Roadmap reference
People

Company team

EI

Eiichiro Ikeda

Representative Executive Officer, President, CEO & Chairperson of Board of Directors

Company leadership profile.

RH

Ryo Hirooka

Representative Executive Officer, CFO & Director

Company leadership profile.

HY

Hiroaki Yoshihara

Lead Independent Director

Company leadership profile.

YA

Yasuyuki Abe

Independent Director

Company leadership profile.

MS

Mototsugu Sato

Independent Director

Company leadership profile.

TH

Takayo Hasegawa

Independent Director

Company leadership profile.

MN

Mika Nishimura

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Hoya Corp.

Orbitrum research

Experts evaluating HOYA Corporation

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment